Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending June 2012. The report details a specific corporate action regarding share repurchases executed on June 19, 2012, in accordance with shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure and share ownership data.
- Shares Purchased: 1,200,000 Ordinary Shares of 25 pence each.
- Price Range: Highest price paid was 1,477.0 pence per share; lowest price paid was 1,453.5 pence per share.
- Treasury Holdings (Settled): 465,507,927 shares, representing 8.52% of total issued share capital.
- Treasury Holdings (Including Unsettled): 469,707,927 shares, representing 9.39% of current total voting rights.
- Shares in Issue (Excluding Treasury): 5,000,310,739 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 1,200,000 shares for Treasury. Consequently, the percentage of shares held in Treasury increased to 8.52% of issued capital (or 9.39% of voting rights including unsettled trades). The filing does not provide comparative data against prior periods for these specific metrics.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities. No specific risks or contingencies are detailed beyond the standard regulatory conformity statement.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (465,507,927 settled) against the company's latest capitalization table.
- Confirm the calculation of voting rights, noting that 9.39% of total voting rights are held in Treasury including unsettled purchases.
- Check the denominator for disclosure obligations under the Financial Services Authority's Disclosure and Transparency Rules, which is 5,000,310,739 shares.
- Review the price range paid (1,453.5 to 1,477.0 pence) to assess the cost of capital relative to market prices on June 19, 2012.